(S)-2-{(S)-4-Carboxy-2-[(S)-3-(4-hydroxy-phenyl)-2-octanoylamino-propionylamino]-butyrylamino}-4-methyl-pentanoic acid

ID: ALA379316

Chembl Id: CHEMBL379316

PubChem CID: 44412423

Max Phase: Preclinical

Molecular Formula: C28H43N3O8

Molecular Weight: 549.67

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O

Standard InChI:  InChI=1S/C28H43N3O8/c1-4-5-6-7-8-9-24(33)29-22(17-19-10-12-20(32)13-11-19)27(37)30-21(14-15-25(34)35)26(36)31-23(28(38)39)16-18(2)3/h10-13,18,21-23,32H,4-9,14-17H2,1-3H3,(H,29,33)(H,30,37)(H,31,36)(H,34,35)(H,38,39)/t21-,22-,23-/m0/s1

Standard InChI Key:  ARVTVHARLYVZJW-VABKMULXSA-N

Associated Targets(non-human)

PRE2 Proteasome Macropain subunit PRE2 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRE1 Proteasome Macropain subunit (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRE7 Proteasome component C5 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 549.67Molecular Weight (Monoisotopic): 549.3050AlogP: 2.75#Rotatable Bonds: 19
Polar Surface Area: 182.13Molecular Species: ACIDHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.52CX Basic pKa: CX LogP: 3.34CX LogD: -3.12
Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.14Np Likeness Score: 0.31

References

1. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R..  (2006)  Development of lipopeptides for inhibiting 20S proteasomes.,  16  (12): [PMID:16630721] [10.1016/j.bmcl.2006.03.033]

Source